Clinical Trials on Glabellar Crease

Total 10000 results

City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Hormone Receptor Positive Breast Carcinoma | Metastatic Breast Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Metastatic Breast Carcinoma | Peritoneal Effusion

United States
Gilead Sciences

Active, not recruiting

Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)

Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast Cancer

Japan
Virginia Commonwealth University
Eli Lilly and Company; Bayer

Terminated

2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer

Breast Cancer | Metastatic Breast Cancer | Recurrent Breast Cancer

United States
Puma Biotechnology, Inc.

Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer (ALISCA-Breast1)

Metastatic Breast Cancer | Recurrent Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer

United States, Spain, Portugal
Nanogen Pharmaceutical Biotechnology Joint Stock...
Vietstar Biomedical Research; MedProve Inc

Completed

Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients

Breast Cancer Recurrent | Breast Cancer Female | Breast Cancer Metastatic

Vietnam
Nanogen Pharmaceutical Biotechnology Joint Stock...
Vietstar Biomedical Research; MedProve Inc

Completed

Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients.

Breast Cancer Recurrent | Breast Cancer Female | Breast Cancer Metastatic

Vietnam
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma

United States, Peru
Hoffmann-La Roche

Completed

A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer (ProHer)

Inflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast Cancer

Canada, Spain, Croatia, Bosnia and Herzegovina, Costa Rica, Singapore, Bulgaria, South Africa, Kenya, Brazil, India, Chile, Peru, Argentina, South Korea, Turkey (Türkiye), Mexico
Massachusetts General Hospital

Enrolling by invitation

The BEACON Trial: Diagnostic Tools for Breast Lymphedema After Treatment for Breast Cancer (BEACON)

Lymphedema | Lymphedema, Breast Cancer | Breast Lymphedema | Breast Edema

United States
BeiGene

Active, not recruiting

BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Hormone Receptor Positive Malignant Neoplasm of Breast | HER2-negative Breast Cancer | Hormone-receptor-positive Breast Cancer

China
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Suspended

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

Invasive Breast Carcinoma | HER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIC Breast Cancer AJCC v7 | Breast Adenocarcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer

Metastatic Malignant Neoplasm in the Bone | Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive

United States
West German Study Group
AstraZeneca

Recruiting

Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based Treatment (CAPIcorn)

Breast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HR-positive Breast Cancer | HER2-negative Breast Cancer

Belgium, Germany, Portugal
XEOS Medical

Completed

Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer (BrIMA)

Breast Cancer | Breast Cancer Invasive | Breast Cancer in Situ

Belgium
George T. Budd
United States Department of Defense; Anixa Biosciences, Inc.

Active, not recruiting

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Residual Disease | TNBC - Triple-Negative Breast Cancer | Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer

United States
Peking University People's Hospital

Not yet recruiting

Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer

Advanced Breast Cancer | HER2 + Breast Cancer
University Hospital, Basel, Switzerland

Recruiting

Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study (MACRONAC)

Breast Cancer

Switzerland
Washington University School of Medicine

Not yet recruiting

Precision Supplemental Imaging in Women With Dense Breasts (PSID)

Breast Cancer | Cancer of the Breast

United States
West German Study Group
Berlin-Chemie Menarini

Recruiting

Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC (ADAPTela)

Breast Cancer | HR+/HER2- Breast Cancer

Germany
Institut Claudius Regaud

Recruiting

Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers (ESPRESSOBREAST)

Metastatic Breast Cancer | Early Breast Cancer

France
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Not yet recruiting

The Effect of Health Education Conducted Using Two Different Methods on Women's Knowledge of Breast Cancer, Health Beliefs, Mammography Self-Efficacy, and Participation in Screening Programs

Breast Cancer | Breast - Female
Nova Scotia Health Authority
Obafemi Awolowo University

Not yet recruiting

De-escalating Axillary Surgery in Breast Cancer Patients in Nigeria

Breast Cancer | Axilla; Breast
Washington University School of Medicine
The Foundation for Barnes-Jewish Hospital; Varian Medical Systems

Recruiting

Cryoablation vs Lumpectomy in T1 Breast Cancers (COOL-IT)

Breast Cancer | Breast Neoplasm

United States
Hospices Civils de Lyon

Recruiting

Immediate Breast Reconstruction's Increasing (IBRI)

Breast Cancer | Breast Reconstruction

France
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy

Breast Cancer | Breast Neoplasms | Breast Adenocarcinoma

United States
Azienda USL Reggio Emilia - IRCCS

Active, not recruiting

Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study (VocRehab)

Breast Cancer | Breast Neoplasm

Italy
Centre Antoine Lacassagne

Completed

Preoperative Localization of Infraclinical Breast Tumors: Isotopic Localization by iodine125 Seed Versus Standard Localization Using a Metal Wire (IodineBreast)

Breast Cancer

France
University of Pennsylvania

Active, not recruiting

[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer (ISO-1Primary)

Breast Cancer | Breast Neoplasm

United States
University of Arizona

Completed

Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors

Breast Cancer

United States
Zuyderland Medisch Centrum

Completed

Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors (CEMMAG)

Breast Cancer

Netherlands
Stanford University

Completed

Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing Mastectomy

Breast Carcinoma | Breast Disorder

United States
The Netherlands Cancer Institute

Terminated

Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

Breast Cancer

Netherlands
University of Houston
American Cancer Society, Inc.; Herald Cancer Association

Completed

Health Benefits of Expressive Writing: Study One (Komen)

Breast Cancer | Breast Neoplasm

United States
photonamic GmbH & Co. KG

Terminated

Fluorescence-guided Resection in Breast Cancer

Breast Tumour

Germany
Mothaffar Rimawi
Genentech, Inc.

Terminated

Neoadjuvant Herceptin in Patients With Breast Cancer

BREAST CANCER

United States
Maastricht Radiation Oncology

Completed

Outpatient Clinic for Late Outcome for Breast Carcinoma in MAASTRO Clinic.

Breast Cancer

Netherlands
University of North Carolina, Chapel Hill

Terminated

Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors

Breast Cancer

United States
Roswell Park Cancer Institute
Pfizer

Completed

Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice

Breast Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Breast Carcinoma

United States
Cedars-Sinai Medical Center

Not yet recruiting

Together-Breast Cancer Support Platform (Together)

Breast Cancer | Breast Cancer Survivors

United States
University of California, San Francisco
Society of Interventional Radiology Foundation; Galvanize Therapeutics, Inc.

Not yet recruiting

Pulsed Electric Field Ablation for Metastatic Breast Cancer

Breast Cancer | Metastatic Breast Cancer

United States
Istituto Oncologico Veneto IRCCS

Not yet recruiting

IntraOperative UltraSound Guided vs Wire Guided vs Magnetic Seed Guided Breast-Conserving Surgery for Non-palpable Tumors (MANOLA)

Breast Cancer | Breast-Conserving Surgery

Italy
Institute of Oncology Ljubljana

Completed

Correlation Between Tumor-infiltrating Lymphocytes and Response to Systemic Therapy in Breast Cancer

Breast Cancer | Early Breast Cancer

Slovenia
Assistance Publique - Hôpitaux de Paris
Institut Pasteur

Completed

Prolactin Receptor and Breast Diseases (Prolacsein)

Breast Cancer | Benign Breast Disease

France
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

Recurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | HER2-positive Breast Cancer | Advanced Breast Carcinoma | HER2-Positive Breast Carcinoma

United States
Thomas Jefferson University
National Cancer Institute (NCI)

Completed

Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions

United States
Ohio State University Comprehensive Cancer Center

Completed

Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors

Obesity | Overweight | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast... and other conditions

United States
Roswell Park Cancer Institute

Terminated

Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors

Obesity | Overweight | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast... and other conditions

United States

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations